Clinical trial
A Long-term Safety Study of Infliximab (Remicade)
NCT00261976 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00261976 |
|---|---|
| Title | A Long-term Safety Study of Infliximab (Remicade) |
| Official title | Long-term Safety Follow-up of REMICADE (RESULTS) |
| Lead sponsor | Centocor, Inc., Industry |
| Collaborators | Centocor BV Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Arthritis, Rheumatoid, Crohn Disease, Psoriasis |
| Intervention type | Drug |
| Interventions | Infliximab (Remicade) |
| Enrollment | 2,971 |
| Start date | Feb 1, 2002 |
| Primary completion | Mar 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Dec 6, 2005 |
| Last update posted | Mar 18, 2014 |
| Countries | Argentina, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hungary, Ireland, Israel, Netherlands and 7 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: